Pulsed high-dose cefotaxime therapy in refractory Lyme borreliosis

The Lancet

Volumn 338, Issue 8760, 1991, Pages 193-

  Hassler, Dieter ^a   Riedel, K ^a   Zorn, J ^a   Preac Mursic, V ^a  

^a Untere Hofstatt 1 D 7527 Kraichtal 1 Germany ^*

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; DOXYCYCLINE; PENICILLIN G;

ADULT; CASE REPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LYME DISEASE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; CASE REPORT; CEFOTAXIME; DRUG ADMINISTRATION SCHEDULE; HUMAN; INFUSIONS, INTRAVENOUS; LYME DISEASE; MALE; MIDDLE AGE; RECURRENCE;

EID: 0025875723     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(91)90188-U     Document Type: Letter

References (3)

1. Treatment of late Lyme borreliosis: randomised comparison of ceftriaxone and penicillin
2. Cefotaxime versus penicillin in the late stage of Lyme disease: prospective randomised therapeutic study
3. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis